Literature DB >> 11468179

Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes.

A Conconi1, F Bertoni, E Pedrinis, T Motta, E Roggero, S Luminari, C Capella, M Bonato, F Cavalli, E Zucca.   

Abstract

Nodal marginal zone B-cell lymphoma (MZL) is a rare and not extensively studied entity that accounts for approximately 2% of all non-Hodgkin lymphomas. Complementarity-determining regions 2 and 3 (CDR2, CDR3) of the immunoglobulin heavy-chain variable region (V(H)) genes were amplified by polymerase chain reaction (PCR), cloned, and sequenced in 8 patients with nodal MZL. All showed a potentially functional V(H) rearrangement. The use of V(H) gene families was unbiased and without overrepresentation of any particular V(H) gene or gene family. The presence of somatic V(H) mutations was detected, with a deviation from the closest germ line sequence ranging from 4% to 17% in 6 of 8 patients. In 3 mutations, the replacement-to-silent mutation ratio suggested the presence of an antigen-selected process. Sequencing different subclones of the same cloned PCR products allowed the detection of intraclonal variability in 4 analyzed patients. The observed pattern of V(H) mutations suggested that nodal MZL, formerly deemed a malignancy of memory B cells, may arise from different subsets of marginal zone B cells-the naive B cells that express unmutated V(H) genes-from memory B cells showing somatic mutations without intraclonal variation, and from germinal center B cells defined by their capacity to undergo the somatic hypermutation process. (Blood. 2001;98:781-786)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468179     DOI: 10.1182/blood.v98.3.781

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.

Authors:  Xavier Sagaert; Brigitte Maes; Vera Vanhentenrijk; Mathijs Baens; Eric Van Cutsem; Gert De Hertogh; Karel Geboes; Thomas Tousseyn
Journal:  World J Gastrointest Oncol       Date:  2011-02-15

2.  Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.

Authors:  Yasodha Natkunam; Izidore S Lossos; Behnaz Taidi; Shuchun Zhao; XiaoQing Lu; Feying Ding; Anne Sofie Hammer; Teresa Marafioti; Gerald E Byrne; Shoshana Levy; Roger A Warnke; Ronald Levy
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

3.  Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.

Authors:  Mohamed E Salama; Izidore S Lossos; Roger A Warnke; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2009-07       Impact factor: 2.493

4.  Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.

Authors:  Anne Tierens; Jan Delabie; Agnieszka Malecka; Junbai Wang; Alicja Gruszka-Westwood; Daniel Catovsky; Estella Matutes
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 5.  Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.

Authors:  Michiel van den Brand; J Han J M van Krieken
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

Review 6.  Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.

Authors:  Sung Yong Oh; Cheolwon Suh
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

Review 7.  Recent advances in understanding the biology of marginal zone lymphoma.

Authors:  Francesco Bertoni; Davide Rossi; Emanuele Zucca
Journal:  F1000Res       Date:  2018-03-28

8.  IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.

Authors:  Massimo Granai; Teresa Amato; Arianna Di Napoli; Raffaella Santi; Federica Vergoni; Gioia Di Stefano; Virginia Mancini; Sofya Kovalchuk; Emanuele Cencini; Alberto Giulio Carta; Sara Aversa; Marita Ziepert; Gabriele Cevenini; Stefano Lazzi; Lorenzo Leoncini; Cristiana Bellan
Journal:  Virchows Arch       Date:  2019-12-04       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.